PaperJJournal of Ethnopharmacology17d agoIntegrated LC-MS/MS profiling, network pharmacology and experimental validation reveal inhibition of the IL-6/JAK2/STAT3 pathway by Shenqi Compound in comorbid chronic pancreatitis and type 2 diabetes mellitusYi Su·Xiaoxu Fu·Xianru Gong·Jiahong Zhang·Yunhui Chen·李祥龙·Rui Peng·Zhima Zeji·Yulin Leng·Heng YangRead at Journal of EthnopharmacologyShareLess like thisTagsPancreatitis Pathology and TreatmentSurgery
